Ontogeny of imidazoline binding sites in the human placenta

Acta Obstetricia et Gynecologica Scandinavica

Volumn 78, Issue 2, 1999, Pages 89-92

  Bagaméry, Krisztina ^a,b   Kovács, László ^a   Viski, Sándor ^a   Nyári, Tibor ^a   Falkay, György ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b WHO Collaborating Ctr for R   (Hungary)

Author keywords

Imidazoline binding site; Ontogeny; Placenta; Radioligand binding techniques

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; IDAZOXAN; IMIDAZOLINE RECEPTOR; RADIOLIGAND; RAUWOLSCINE;

ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; ONTOGENY; PLACENTA; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0032905620     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1080/j.1600-0412.1999.780203.x     Document Type: Article

References (16)

1. 3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. J Pharmacol Exp Ther 1992; 264: 1187-97.
2. 2. Diamant S, Eldar-Geva T, Atlas D. Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function. Br J Pharmacol 1992; 106: 101-8.
3. 3. Olmos G, Miralles A, Barturen F, Garcia-Sevilla JA. Repeated idazoxan increases brain imidazoline receptors in normotensive but not hypertensive rats. J Neurochem 1991; 57: 1811-13.
4. 4. Ernsberger P, Meeley NP, Reis DJ. An endogenous substance wih clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla. Brain Res 1988; 441: 309-18.
5. 5. Atlas D, Burnstein Y. Isolation and partial purification of a clonidine-displacing endogenous brain substance. Eur J Pharmacol 1984; 144: 287-93.
6. 6. Bousquet P, Feldman J, Atlas D. An endogenous non catecholamine clonidine antagonist increases mean arterial blood pressure. Eur J Pharmacol 1986; 124: 167-70.
7. 7. Gradey-Levassort G, Ventura MA, Thiroux G, Olive G. An attempt to identify α-adrenoceptors in the human placenta. Dev Pharmacol Ther 1984; 7: 85-8 (Suppl 1).
8. 2-adrenergic receptors and imidazoline binding sites coexist in the human term placenta? Evidence from direct binding studies. Mol Hum Reprod 1998; 4: 384-91.
9. 9. Falkay G, Melis K, Kovács L. Correlation between beta-and alpha-adrenergic receptor concentrations in human placenta. J Receptor Res 1994; 14: 187-95.
10. 10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein binding. Anal Biochem 1976; 12: 248-54.
11. 11. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal Biochem 1980; 107: 220-39.
12. 12. Furchgott RF. Role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 1984; 24: 175-97.
13. 13. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 237: 524-6.
14. 14. Khong TY. The Robertson-Brosens-Dixon hypothesis: evidence for the role of haemochorial placentation in pregnancy success. Br J Obstet Gynaecol 1991; 98: 1195-9.
15. 2-adrenoceptor antagonists. J Med Chem 1985; 28: 1054-62.
16. 16. O'Rourke MF, Blaxall HS, Iversen LJ, Bylund DB. Characterization of [3H] RX 821002 binding to alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther 1994; 268: 1362-7.